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Introduction
Morphological changes are required for eukaryotic pathogens to
cause disease. However, it is only now becoming clear how such
transitions are linked to virulence in human pathogenic fungi.
Changing cell size and shape are strategies employed by many of
these fungi to survive in the environment and serendipitously also
within the host. Conserved signaling pathways regulate morpho-
genic differentiation in response to environmental and host
physiological stimuli. The alterations in cell-surface composition
during morphogenesis, in addition to cell size and shape, further
link virulence with morphogenesis.
Morphotype Transition Is Associated with Fungal
Virulence
Changes in morphology are required by diverse microbes to be
successful pathogens, and the well-known examples include
bacterial pathogen Chlamydia trachomatis and protozoan parasite
Plasmodium falciparum. Morphotype transitions are also required for
fungi to cause disease in plants. For example, the rice blast
ascomycete Magnaporthe oryzae undergoes a series of morphotype
changes (conidiaRappressoriaRpenetration pegRinvasive hy-
phae) for infection. The corn smut basidiomycete Ustilago maydis
grows as a yeast in vitro and infects plants only in the hyphal form
after mating.
The majority of fungi grow either filamentously by apical
extension or unicellularly by budding or fission. A few human
pathogenic fungi switch between these two growth forms, and
these are called dimorphic fungi. Here, ‘‘morphotype transition’’
or ‘‘dimorphism’’ refers to the ability to switch between two or
more different growth forms. It has been established in the
‘‘classic’’ dimorphic pathogens (listed in the clade of Ascomycota
in Figure 1) that proper morphotype transition is required for
virulence: blocking transitions by chemicals or genetic mutations
attenuates or abolishes their ability to cause diseases [1–6].
Morphotype-associated pathogenicity is likely more widespread
than just those species traditionally classified as dimorphic. For
instance, Cryptococcus neoformans, a basidiomycetous pathogen, has
both a yeast and a filamentous form. Early studies on natural
Cryptococcus isolates implicated an inverse relationship between
filamentation and virulence (see [7] and references therein). A
molecular link between morphogenesis and virulence in this
fungus was obtained recently through the characterization of the
transcription factor Znf2. Overexpression of the ZNF2 gene
confers filamentation and abolishes the ability of this fungus to
cause disease, while the deletion of the ZNF2 gene locks cells in the
yeast form and enhances virulence [8,9]. The existence of
morphotype-associated pathogenicity is also observed in some
zygomycetes [10] and in dermatophytes [11]. Thus, it appears that
pathogens of different major phyla in the fungal kingdom have
adopted dimorphism as a common pathogenic strategy. The
underlying question is what advantage this provides to these
species.
Changes in Cell Size Impact Fungal Pathogenicity
Cell size affects multiple steps during infection and disease
progression. As infectious propagules, spores of small sizes are
ideal for dispersal and entry into host lungs. For instance,
Cryptococcus spores (1–2 mm in diameter) are easily lodged into
the lower respiratory tract and phagocytosed by lung macrophages
[12,13]. Spores then germinate into encapsulated yeasts of varied
sizes. These yeast cells can withstand the antimicrobial activities
mediated by macrophages, proliferate intracellularly, and escape
from the host cell. Mycelia of Histoplasma capsulatum produce two
types of conidia, macroconidia (8–16 mm), and microconidia (2–
5 mm). The microconidia enter the alveolar spaces and germinate
into budding yeasts that can persist intracellularly in phagocytotic
cells, a critical step for Histoplasma infection [14]. However, for
fungal pathogens that typically infect the upper respiratory tract,
gastrointestinal tract, or subcutaneous tissues, cell size has a
different impact on virulence. The zygomycete Mucor circinelloides f.
lusitanicus is a heterothallic fungus with (+) or (2) mating types.
Asexual spores produced by (2) strains are larger and can
germinate inside macrophages and lyse host cells. Accordingly, the
spores produced by (2) strains are more virulent [10]. A key
observation is that allowing small spores to germinate and develop
into large cells in vitro, prior to the infection, increases the
virulence of the inoculum [10].
Heterogeneity in cell size is a bet-hedging strategy that poises a
population of cells of identical genotype for different contingencies
in the host. For instance, a subset of Cryptococcus yeast cells enlarge
from the typical 3–5 mm to up to 100 mm in diameter during later
stages of lung infection [15,16]. These giant cryptococcal cells can
evade phagocytosis and better tolerate oxidative and nitrosative
stresses. A mutant defective in producing these large cells has
attenuated virulence [17]. Similarly, Paracoccidioides brasiliensis wild-
type populations show varied cell size, and mutant cells
homogenously reduced in size are more susceptible to phagocy-
tosis by macrophages and are unable to cause disease [18].
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Changing Cell Shape or Size May Have Evolved as
a Response to Environmental Stresses
The majority of the human fungal pathogens are environmental
saprophytes (Figure 1), and their ability to survive in a mammalian
host is a consequence of selective pressures posed by their
environment. Changing cell shape or size is likely an adaptive trait
that is also advantageous when these pathogens encounter the
host. Accordingly, signaling pathways that play important roles in
coordinating morphological changes and virulence (see the next
section) are typically involved in sensing environmental stresses.
Of these stresses, high body temperature presents a major
barrier for many fungal species to infect mammals. This barrier
may explain the rarity of fungal diseases in humans, in contrast to
the prevalence of fungal diseases in plants, insects, amphibians, or
even bats during hibernation [19]. Interestingly, elevated temper-
atures are the primary signal directing dimorphic fungi to switch
from the saprotrophic filamentous phase to the pathogenic yeast
phase (Figure 1).
Conserved Signaling Pathways Orchestrate both
Morphogenesis and Virulence
Ancient signaling pathways that respond to environmental cues
control fungal morphogenesis and virulence. These include the
cAMP/PKA pathway, the PKC cell wall integrity pathway, the
pheromone sensing pathway, the Ca2+-calcineurin pathway, and
the two-component pathways [2,20] that are found across the
fungal kingdom. Most of these signaling pathways are involved in
regulating temperature stress. However, those pathways are also
present in nonpathogenic species: how temperature is translated
into morphogenesis in the pathogens remains an open question
and the responsible thermosensors elusive. One promising
candidate thermosensor is the histidine kinase Drk1, which
triggers the temperature-dependent dimorphic transition in
Histoplasma and Blastomyces [2]. Interestingly, its bacterial homolog
DesK is the first documented histidine kinase that senses
temperature fluctuations by detecting changes in membrane
thickness [21]. The heat-shock chaperone Hsp90 plays important
roles in the temperature-regulated dimorphism in Candida, and
regulators Ryp1-3 are critical for the temperature-induced
filament-to-yeast switch of Histoplasma [5,6,22]. However, these
molecules likely sense temperatures indirectly via some unfolded
proteins or act downstream of thermosensors. Besides proteins,
RNAs with temperature-sensitive structures could also act as
thermosensors, as shown in some bacterial pathogens [23].
In addition to exogenous factors (e.g., temperature, osmolarity,
serum, pH, and sugar), endogenously produced small molecules
such as quorum-sensing molecules (QSMs) affect fungal morpho-
genesis. QSMs regulate biological processes in a population
density–dependent manner. In C. albicans, farnesol inhibits yeast-
to-filament conversion in correlation with the inoculum size [24].
Tyrosol, on the other hand, stimulates yeast-to-filament conver-
sion [25]. Multiple QSMs (e.g., farnesol, tyrosol, and morpho-
genic autoregulatory substance) likely fine-tune the dimorphic
transition in C. albicans. Inoculum size is shown to affect
morphotype transition in other dimorphic fungi [25], implying
that QS systems are widely used to synchronize fungal cellular
differentiation. Given that ‘‘anti-quorum sensing’’ is being
exploited to curb bacterial virulence and that QS quenchers
are less likely to select for resistance compared to conventional
antimicrobial drugs [26], investigation into the QS response
systems in fungi could help design effective treatments against
mycoses.
Figure 1. Fungal pathogens from different phyla exhibit a dimorphic lifestyle. Candida albicans is a commensal or opportunistic pathogen,
distinguishing it from the other species that are acquired from environmental exposure. The factors regulating dimorphism are provided: H2O
2
dehydration; H2O
+ aqueous environment.
doi:10.1371/journal.ppat.1003027.g001
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Alterations in the Cell Surface Are Underpinned
by Cellular Morphology
Changes in cell shape or size are a visual manifestation of
alterations in cell-wall properties. Although important, the physical
aspects of shape and size may not by themselves be the key factor
controlling virulence. Rather, alterations in cell surface molecules
during morphogenesis help fungi to adapt to host conditions and to
avoid or defend against host immune attacks. In B. dermatitidis, H.
capsulatum, and P. brasiliensis, filament-to-yeast transition is accom-
panied by the increased production of a-1,3-glucan [14,27], which
masks the immunostimulatory b-glucan [28]. In C. albicans, the
pathogenic hyphal growth form does not expose b-glucan to trigger
antimicrobial responses [29]. In C. neoformans, spores germinate into
yeast cells with enlarged capsule under host-relevant conditions.
The capsule is immune-suppressive and antiphagocytotic, and it
conceals antigens that could be recognized by the host.
A repertoire of cell-surface adhesion proteins (adhesins) are
highly regulated during morphotype switches: some adhesins are
specifically expressed in the pathogenic form, while others in the
saprotrophic/commensal form. In M. oryzae, the integral mem-
brane protein Pls1 regulates adhesion with Teflon-binding affinity
to the plant surface and is specifically expressed in the
appressorium [30], a cell type used for penetrating the plant
tissue. In the human pathogenic fungi, adhesin Bad1 of B.
dermatitidis is specifically expressed in the pathogenic yeast form
[1], and it controls multiple processes during infection [31].
Adhesin Hwp1 in C. albicans is specifically expressed in hyphae to
assist fungal attachment to epithelial cells, and Hwp1 is required
for systemic candidiasis [32]. Als3, another adhesin expressed in
Candida hyphae, binds to multiple host receptors and induces its
own endocytosis to facilitate fungal penetration of epithelial cells
[33]. By contrast, the adhesin Cfl1 in C. neoformans is associated
with nonpathogenic filaments, and forced expression of Cfl1 in the
pathogenic yeast form attenuates virulence [8]. Cfl1 is a
downstream target of Znf2, which controls the expression of
multiple adhesion genes in Cryptococcus (unpublished results).
Accordingly, the znf2D mutant is more virulent than the wild
type, even though both strains are in the yeast form during
infection [8,9]. Taken together, alterations in cell surface in
addition to the physical cell shape and size likely underpin the link
between morphogenesis and fungal virulence.
In the pathogenic fungi that are acquired from environmental
sources, the filamentous form is generally not pathogenic. None-
theless, adhesins or other molecules on filaments or spores help
shape the initial interactions between the host and the pathogen
(Figure 2), which establishes subsequent host-pathogen interactions.
Success by these fungi to colonize the host, establish infections, and
disseminate systemically is a combination of the downregulation of
filament- or spore-specific molecules and upregulation of the yeast-
specific ones. Therefore, investigation of cell-surface molecules
specific to each morphological form will provide a new opportunity
to comprehend host-fungus interactions.
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